Vermont Agency of Administration
State AgencyVT
Jul 27, 2026
Closes
Aug 28, 2026
Sos Next Generation Licensing Platform O&m Support RFP
Provide SOS Next Generation Licensing Platform O&M Support.
Description: The Vermont Office of Purchasing and Contracting issued this Request for Proposal on behalf of the State of Vermont for operation and maintenance support for a next-generation licensing platform. The solicitation is a statewide information-technology procurement, with proposals due on August 28, 2026 at 4:30 PM Eastern Time. Bid documents, notifications, releases, and amendments are to be obtained from and monitored through the official Vermont purchasing page.
State · VT, US
Original attachments and procurement documents tied to this bid.
No files attached to this RFP.
Many agencies add documentation later or require FOIA requests. Starbridge can automatically retrieve these files for you.
Request File RetrievalAdjacent opportunities open for bidding right now.
Vermont Agency of Administration
State AgencyVT
Jul 27, 2026
Closes
Aug 28, 2026
Provide SOS Next Generation Licensing Platform O&M Support.
CountyIN
Jul 20, 2026
Closes
Aug 31, 2026
The cad consortium envisions a unified, next-generation computer aided dispatch (cad) system that seamlessly connects all participating psaps and first responder agencies across the region. The future state will enable real-time data sharing, coordinated incident response, and enhanced situational awareness for all police, fire, and ems operations, regardless of jurisdiction.
Jun 4, 2026
Closes
Dec 3, 2026
A novel platform for improving the safety and effectiveness of therapeutic gas-based treatments by enabling controlled, localized delivery at the site of disease. By addressing longstanding challenges associated with systemic exposure and dosing precision, the platform enhances the clinical viability of gas therapies across high-value markets such as oncology, cardiovascular care, and regenerative medicine. In addition, the inclusion of a complementary predictive modeling capability supports treatment optimization and development efficiency, reducing technical risk and accelerating translation. Together, these capabilities position the technology as a differentiated and scalable solution that can unlock new commercial opportunities in areas where gas-based therapeutics have shown promise but faced delivery limitations.
Jun 15, 2026
Closes
Dec 15, 2026
The bacterial lipid nanodiscs platform developed by llaboratory provides a new way to study entire bacterial membranes in a controlled, nanoscale format derived directly from native lipid extracts. Researchers gain access to membrane components that typically remain difficult to isolate, stabilize or analyze, enabling more accurate evaluation of immunogenic lipids and membrane associated targets. The platform offers a safer alternative to handling live high risk pathogens while preserving the biological context that drives meaningful insights for vaccine design and antimicrobial discovery such as therapeutic antibodies to conserved lipids on bacterial membranes.
Procurement and program contacts connected to State of Vermont.